Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scynexis Inc (SCYX)

Scynexis Inc (SCYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scynexis Inc 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302 USA

www.scynexis.com Employees: 29 P: 201-884-5485

Description:

SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 45,539
Enterprise Value, $K 11,109
Shares Outstanding, K 37,949
Annual Sales, $ 140,140 K
Annual Net Income, $ 67,040 K
Last Quarter Sales, $ 660 K
Last Quarter Net Income, $ -2,810 K
EBIT, $ -52,130 K
EBITDA, $ -48,560 K
60-Month Beta 1.50
% of Insider Shareholders 2.85%
% of Institutional Shareholders 54.37%
Float, K 36,867
% Float 97.15%
Short Volume Ratio 0.35

Growth:

1-Year Return -27.71%
3-Year Return -83.17%
5-Year Return -89.09%
5-Year Revenue Growth 53,800.00%
5-Year Earnings Growth 128.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/06/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.90
EPS Growth vs. Prev Qtr 80.00%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/17/20

SCYX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -66.21%
Return-on-Assets % -38.84%
Profit Margin % 47.84%
Debt/Equity 0.00
Price/Sales 0.34
Price/Cash Flow 0.66
Price/Book 0.81
Book Value/Share 1.55
Interest Coverage 22.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar